Relationship Between Adipokines, Inflammation, and Vascular Reactivity in Lean Controls and Obese Subjects with Metabolic Syndrome
Overview
Authors
Affiliations
Purpose: Metabolic syndrome is an important risk factor for cardiovascular disease. Adipokines interfere with insulin action and endothelial cell function. We investigated the relationship among adipokines, metabolic factors, inflammatory markers, and vascular reactivity in obese subjects with metabolic syndrome and lean controls.
Methods: Cross-sectional study of 19 obese subjects with metabolic syndrome and 8 lean volunteers evaluated as controls. Vascular reactivity was assessed by venous occlusion pletysmography measuring braquial forearm blood flow (FBF) and vascular resistance (VR) responses to intra-arterial infusions of endothelium-dependent (acetylcholine-Ach) and independent (sodium nitroprusside-SNP) vasodilators. Blood samples were obtained to evaluate C reactive protein (CRP), plasminogen activator inhibitor 1 (PAI-1), fibrinogen, adiponectin, resistin, and lipid profile. Patients were classified with regard to insulin resistance through the HOMA-IR index.
Results: PAI-1, CRP and fibrinogen were higher and adiponectin was lower in metabolic syndrome subjects compared to controls. Metabolic syndrome subjects had impaired vascular reactivity. Adiponectin and PAI-1 were associated with insulin, HOMA-IR, triglycerides, and HDLc; and resistin with CRP. Adiponectin was associated with VR after Ach in the pooled group and resistin with D FBF after Ach in the metabolic syndrome group.
Conclusion: Metabolic syndrome subjects exhibited low levels of adiponectin and high levels of CRP, fibrinogen, and PAI-1. Adiponectin and PAI-1 correlated with insulin resistance markers. Adiponectin and resistin correlated with vascular reactivity parameters. An adipocyte-endothelium interaction might be an important mechanism of inflammation and vascular dysfunction.
Adiponectin reverses β-Cell damage and impaired insulin secretion induced by obesity.
Munhoz A, Serna J, Vilas-Boas E, Caldeira da Silva C, Santos T, Mosele F Aging Cell. 2023; 22(6):e13827.
PMID: 37060190 PMC: 10265168. DOI: 10.1111/acel.13827.
Musialik K, Miller-Kasprzak E, Walczak M, Markuszewski L, Bogdanski P Nutrients. 2022; 14(9).
PMID: 35565757 PMC: 9102533. DOI: 10.3390/nu14091789.
Zaidi H, Byrkjeland R, Njerve I, Akra S, Solheim S, Arnesen H Adipocyte. 2021; 10(1):612-620.
PMID: 34779349 PMC: 8726619. DOI: 10.1080/21623945.2021.1996699.
Ahmed O, Hassan N, Azhar A, El-Mas M, El-Bassossy H Front Pharmacol. 2021; 12:696981.
PMID: 34456723 PMC: 8385560. DOI: 10.3389/fphar.2021.696981.
Cevikelli-Yakut Z, Ozcelik R, Cevik O, Sener T, Sener G Int J Impot Res. 2020; 33(8):844-853.
PMID: 33009496 DOI: 10.1038/s41443-020-00356-w.